Published in J Gerontol A Biol Sci Med Sci on February 16, 2009
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J Womens Health (Larchmt) (2013) 2.81
Clinical practice. Calcium supplements and fracture prevention. N Engl J Med (2013) 2.78
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr (2011) 2.44
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab (2010) 1.64
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol (2011) 1.52
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer (2011) 1.20
Total mortality risk in relation to use of less-common dietary supplements. Am J Clin Nutr (2010) 1.15
Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health (2014) 1.10
Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol (2011) 1.09
Nonclassical vitamin D action. Nutrients (2010) 1.02
Osteoporosis prevention, screening, and treatment: a review. J Womens Health (Larchmt) (2014) 1.01
Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr (2011) 1.00
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res (2011) 0.95
Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J (2013) 0.95
A review of calcium supplements and cardiovascular disease risk. Adv Nutr (2012) 0.94
Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI). Am J Clin Nutr (2011) 0.94
Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep (2011) 0.88
Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One (2013) 0.87
Vitamin D and cancer mortality in elderly women. BMC Cancer (2015) 0.85
Update on the Vitamin D and OmegA-3 trial (VITAL). J Steroid Biochem Mol Biol (2015) 0.85
Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.83
25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study. J Intern Med (2014) 0.83
Role of vitamin D receptor activation in racial disparities in kidney disease outcomes. Semin Nephrol (2013) 0.82
Food Fortification and Supplement Use-Are There Health Implications? Crit Rev Food Sci Nutr (2016) 0.82
Is excess calcium harmful to health? Nutrients (2010) 0.81
Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol (2016) 0.81
Does calcium intake affect cardiovascular risk factors and/or events? Clinics (Sao Paulo) (2012) 0.81
Extraskeletal effects and manifestations of Vitamin D deficiency. Indian J Endocrinol Metab (2013) 0.81
Vitamin D and cardiovascular disease. Nutrients (2010) 0.80
Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials. Womens Health (Lond Engl) (2011) 0.78
Role of Vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? Biomed Res Int (2015) 0.78
The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink. BMC Cancer (2015) 0.78
Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, [corrected] controlled trial (SYSDIET). Eur J Nutr (2014) 0.77
Mitigating epidemic vitamin D deficiency: the agony of evidence. Can Fam Physician (2011) 0.77
Calcium Supplements and Cardiovascular Disease: A Review. Am J Lifestyle Med (2015) 0.76
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76
Knowledge and attitudes about vitamin D, and behaviors related to vitamin D in adults with and without coronary heart disease in Saudi Arabia. BMC Public Health (2017) 0.75
Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Adv Nutr (2017) 0.75
Calcium: too much of a good thing? J Womens Health (Larchmt) (2013) 0.75
An estimate of the survival benefit of improving vitamin D status in the adult german population. Dermatoendocrinol (2009) 0.75
Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial. Menopause (2016) 0.75
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr (2007) 9.61
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 7.87
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med (2008) 7.21
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics (2000) 6.19
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr (2006) 4.74
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control (2005) 4.29
Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med (2006) 4.09
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol (2003) 2.42
Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke (1999) 2.41
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer (2006) 2.38
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
The association between low bone mass at the menopause and cardiovascular mortality. Am J Med (1999) 2.30
Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet (1991) 1.78
Dietary intake of calcium in relation to mortality from cardiovascular disease: the JACC Study. Stroke (2005) 1.51
Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr (1993) 1.45
Effect of age on blood acid-base composition in adult humans: role of age-related renal functional decline. Am J Physiol (1996) 1.36
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol (2006) 1.33
Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke (1996) 1.33
Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab (2004) 1.25
Potassium bicarbonate reduces urinary nitrogen excretion in postmenopausal women. J Clin Endocrinol Metab (1997) 1.23
The 25-hydroxyvitamin D threshold for better health. J Steroid Biochem Mol Biol (2007) 1.14
Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med (1992) 0.92
The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A). Eur J Pediatr (1980) 0.81
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA (2004) 7.68
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
The case for early detection. Nat Rev Cancer (2003) 6.96
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med (2012) 6.46
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA (2006) 5.75
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22